Cargando…
Statins in Candidemia: clinical outcomes from a matched cohort study
BACKGROUND: HMG CoA reductase inhibitors (statins) in patients with bacteremic sepsis have shown significant survival benefits in several studies. There is no data on the effect of statins in candidemic patients, however in-vitro models suggest that statins interfere with ergesterol formation in the...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894022/ https://www.ncbi.nlm.nih.gov/pubmed/20525374 http://dx.doi.org/10.1186/1471-2334-10-152 |